Immune response against toxoplasmosis—some recent updates RH: Toxoplasma gondii immune response

M Sana, M Rashid, I Rashid, H Akbar… - International journal …, 2022 - journals.sagepub.com
Aims Cytokines, soluble mediators of immunity, are key factors of the innate and adaptive
immune system. They are secreted from and interact with various types of immune cells to …

Recent advances in developing vaccines against Toxoplasma gondii: an update

NZ Zhang, M Wang, Y Xu, E Petersen… - Expert Review of …, 2015 - Taylor & Francis
Toxoplasma gondii, a significant public health risk, is able to infect almost all warm-blooded
animals including humans, and it results in economic losses in production animals. In the …

An overview of seventy years of research (1944–2014) on toxoplasmosis in Colombia, South America

WA Cañón-Franco, N López-Orozco… - Parasites & vectors, 2014 - Springer
This paper summarizes prevalence of Toxoplasma gondii in humans and animals and
associated correlates of infection, clinical spectrum of disease in humans, and genetic …

Influence of Two Major Toxoplasma Gondii Virulence Factors (ROP16 and ROP18) on the Immune Response of Peripheral Blood Mononuclear Cells to Human …

A Hernández-de-Los-Ríos, M Murillo-Leon… - Frontiers in cellular …, 2019 - frontiersin.org
Toxoplasma gondii ROP16 and ROP18 proteins have been identified as important virulence
factors for this parasite. Here, we describe the effect of ROP16 and ROP18 proteins on …

SAG4 DNA and Peptide Vaccination Provides Partial Protection against T. gondii Infection in BALB/c Mice

J Zhou, L Wang - Frontiers in microbiology, 2017 - frontiersin.org
Toxoplasma gondii can lead to congenital infections in human. Surface antigen protein 4
(SAG4) of T. gondii is a potential stimulator for humoral and cellular immune responses. In …

Evaluation of the impact of the first evidence-based guidelines for congenital toxoplasmosis in Armenia (Quindío) Colombia: An observational retrospective analysis

M Mejia-Oquendo, E Marulanda-Ibarra… - The Lancet Regional …, 2021 - thelancet.com
Background Colombia implemented the world's first evidence-based guidelines for
congenital toxoplasmosis in 2013, no evaluation of its impact has been reported. Methods …

[HTML][HTML] Colombian ocular infectious epidemiology study (COIES): Ocular Toxoplasmosis incidence and Sociodemographic characterization, 2015-2019

C Cifuentes-González, E Zapata-Bravo… - International Journal of …, 2022 - Elsevier
Objectives This study aims to describe the incidence of ocular involvement in patients with
toxoplasmosis and describe the sociodemographic characteristics by age, sex, and region in …

Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces …

NZ Zhang, Y Xu, M Wang, J Chen, SY Huang… - BMC Infectious …, 2016 - Springer
Background Toxoplasmosis is a worldwide zoonosis caused by the intracellular parasite
Toxoplasma gondii. However, no effective vaccine is yet available. Poly (lactide-co …

[HTML][HTML] Seroprevalencia y detección molecular de Toxoplasma gondii en donantes de un banco de sangre de Cúcuta, Colombia

AM Ramírez, YK Ríos, NF Galvis, E Entrena, NV Mariño… - Biomédica, 2019 - scielo.org.co
Introducción. La infección por Toxoplasma gondii puede presentarse en los humanos con
un amplio rango de manifestaciones que van desde el estado asintomático hasta la …

Genetic polymorphisms in cytokine genes in Colombian patients with ocular toxoplasmosis

CA Naranjo-Galvis, A de-la-Torre… - Infection and …, 2018 - Am Soc Microbiol
Toxoplasmosis is caused by infection with the protozoan parasite Toxoplasma gondii, which
has the capacity to infect all warm-blooded animals worldwide. Toxoplasmosis is a major …